JPMorgan Sees Strong Strategic Value in Potential AbbVie Acquisition of Apogee Therapeutics 
US-Iran De-Escalation Shifts Washington’s Focus to AI Regulation and Crypto Legislation 
John Jumper Leaves Google DeepMind for Anthropic Amid Intensifying AI Talent Race 
Heineken Names JDE Peet’s CEO Rafael Oliveira as New Chief Executive 
WiseTech Global Denies Knowledge of Investigation Into Founder Richard White 
Tencent Reviews Marvelous Stake as Gaming Giant Reassesses Global Investment Strategy 
KPMG Australia Chairman and Senior Partners Exit Amid Escalating Whistleblower Scandal 
100+ Global Companies Push Governments to Prioritize Electrification for Economic Growth 
TD Bank Expands Employee Monitoring Software to Boost Productivity Amid Privacy Concerns 
NHTSA Investigates Fatal Tesla Model 3 Crash in Texas Amid Ongoing Autopilot and FSD Safety Scrutiny 
Meta Pauses Employee Activity Tracking Program Over Data Security Concerns 
Trump’s Quantum Push Lifts IBM Stock as CEO Arvind Krishna Receives White House Praise 
Oracle Cuts 21,000 Jobs as AI Reshapes Workforce and Cloud Expansion Accelerates 
Apollo Debt Solutions Limits Redemptions as Withdrawal Requests Surge 
Ukrainian Drone Makers Target Japan and Asia Defense Market 
California Drivers Sue BP, Walmart, 7-Eleven Over Alleged AI Gas Price Fixing 
China Adds MP Materials, USA Rare Earth to Export Control List Amid Escalating U.S.-China Trade Tensions 
AMSTERDAM, The Netherlands, Feb. 02, 2016 -- Wright Medical Group N.V. (NASDAQ:WMGI) today announced that it will host a conference call on Tuesday, February 23, 2016, at 3:30 p.m. Central Time to discuss the company’s operating results for its fourth quarter ended December 27, 2015. Operating results will be released at 3:00 p.m. Central Time that day.
The live dial-in number for the call is 800-237-9752 (U.S.) / 617-847-8706 (Outside U.S.). The participant passcode for the call is “Wright.” A simultaneous webcast of the call will be available via Wright Medical’s corporate website at www.wright.com. The call will be archived on this site for a minimum of 12 months.
A recording of the call will be available beginning at 5:30 p.m. Central Time on February 23, 2016 through March 1, 2016. To hear this recording, dial 888-286-8010 (U.S.) / 617-801-6888 (Outside U.S.) and enter code 70431489.
Internet Posting of Information
Wright routinely posts information that may be important to investors in the “Investor Relations” section of its website at www.wright.com. The company encourages investors and potential investors to consult the Wright website regularly for important information about Wright.
About Wright
Wright Medical Group N.V. is a global medical device company focused on Extremities and Biologics. The company is committed to delivering innovative, value-added solutions improving quality of life for patients worldwide and is a recognized leader of surgical solutions for the upper extremity (shoulder, elbow, wrist and hand), lower extremity (foot and ankle) and biologics markets, three of the fastest growing segments in orthopedics. For more information about Wright, visit www.wright.com.
Investors & Media: Julie D. Tracy Sr. Vice President, Chief Communications Officer Wright Medical Group N.V. (901) 290-5817 [email protected]
